RhumbLine Advisers’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.76K Sell
928
-18,539
-95% -$55.1K ﹤0.01% 3968
2025
Q1
$63.1K Sell
19,467
-277
-1% -$897 ﹤0.01% 3523
2024
Q4
$78K Sell
19,744
-1,506
-7% -$5.95K ﹤0.01% 3546
2024
Q3
$164K Buy
21,250
+1,156
+6% +$8.94K ﹤0.01% 3330
2024
Q2
$103K Buy
20,094
+19,341
+2,569% +$99.4K ﹤0.01% 3510
2024
Q1
$6.12K Hold
753
﹤0.01% 3951
2023
Q4
$3.01K Hold
753
﹤0.01% 4054
2023
Q3
$3.1K Hold
753
﹤0.01% 4056
2023
Q2
$4.47K Buy
+753
New +$4.47K ﹤0.01% 4113
2022
Q2
Sell
-18,748
Closed -$162K 3251
2022
Q1
$162K Sell
18,748
-1,962
-9% -$17K ﹤0.01% 2801
2021
Q4
$231K Sell
20,710
-535
-3% -$5.97K ﹤0.01% 2794
2021
Q3
$275K Buy
21,245
+860
+4% +$11.1K ﹤0.01% 2801
2021
Q2
$338K Sell
20,385
-1,844
-8% -$30.6K ﹤0.01% 2739
2021
Q1
$382K Sell
22,229
-680
-3% -$11.7K ﹤0.01% 2611
2020
Q4
$359K Buy
22,909
+3,131
+16% +$49.1K ﹤0.01% 2589
2020
Q3
$378K Sell
19,778
-3,320
-14% -$63.5K ﹤0.01% 2416
2020
Q2
$317K Buy
23,098
+6,663
+41% +$91.4K ﹤0.01% 2553
2020
Q1
$175K Sell
16,435
-2,505
-13% -$26.7K ﹤0.01% 2635
2019
Q4
$354K Buy
18,940
+5,269
+39% +$98.5K ﹤0.01% 2516
2019
Q3
$143K Buy
13,671
+450
+3% +$4.71K ﹤0.01% 2823
2019
Q2
$100K Buy
+13,221
New +$100K ﹤0.01% 2932
2018
Q2
Sell
-17,371
Closed -$93K 2931
2018
Q1
$93K Sell
17,371
-300
-2% -$1.61K ﹤0.01% 2748
2017
Q4
$70K Hold
17,671
﹤0.01% 2801
2017
Q3
$77K Buy
17,671
+520
+3% +$2.27K ﹤0.01% 2876
2017
Q2
$81K Sell
17,151
-1,706
-9% -$8.06K ﹤0.01% 2904
2017
Q1
$311K Buy
18,857
+550
+3% +$9.07K ﹤0.01% 2487
2016
Q4
$185K Buy
18,307
+3,563
+24% +$36K ﹤0.01% 2694
2016
Q3
$198K Buy
14,744
+1,400
+10% +$18.8K ﹤0.01% 2683
2016
Q2
$279K Buy
+13,344
New +$279K ﹤0.01% 2574